Brought to you by 
Phytobiotech completes $11mm second round
09 Oct 2002
Executive Summary
Phytobiotech (plant-derived molecules) raised $11mm ($Cdn17.25mm) in a second-round financing led by new investor SGF Santé. Other new investors Investissement Desjardins, T2C2/Bio, and a group of private individuals also participated, along with returning shareholders Fonds de solidarité FTQ, Fonds Bioalimentaire, and Innovatech du Grand Montréal.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
-
Molecular Diversity
- Natural Products
-
Molecular Diversity
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Phytobiotech completes $11mm second round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice